Stephen K. Klasko M.D. - May 9, 2025 Form 4 Insider Report for TELEFLEX INC (TFX)

Role
Director
Signature
Daniel V. Logue w/POA for Stephen K. Klasko
Stock symbol
TFX
Transactions as of
May 9, 2025
Transactions value $
$0
Form type
4
Date filed
5/13/2025, 05:02 PM
Previous filing
Feb 21, 2025
Next filing
May 14, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klasko Stephen K. M.D. Director 550 E SWEDESFORD ROAD, SUITE 400, WAYNE Daniel V. Logue w/POA for Stephen K. Klasko 2025-05-13 0001433241

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFX Common Stock Award $0 +1.36K +17.01% $0.00 9.33K May 9, 2025 Direct F1
holding TFX Common Stock 7.88K May 9, 2025 By Stephen K. Klasko Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFX Stock Option / (Right to Buy) Award $0 +2.23K $0.00 2.23K May 9, 2025 Common Stock 2.23K $125.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders.
F2 If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders.